Non-pangenotypic direct-acting antiviral combinations
WHO आवश्यक दवा EML अनुभाग: Non-pangenotypic direct-acting antiviral combinations
लेबल स्थिति: label not available in our sources
यह केवल जानकारी है, प्रिस्क्रिप्शन नहीं। कोई भी दवा लेने से पहले डॉक्टर या फार्मासिस्ट से सलाह लें। ओवरडोज़/विषाक्तता पर 102 पर कॉल करें।
Listed for: Non-pangenotypic direct-acting antiviral combinations (WHO EML section heading).
What is Ledipasvir/sofosbuvir used for?
It is listed for: Non-pangenotypic direct-acting antiviral combinations (WHO Model List section).
Is Ledipasvir/sofosbuvir an essential medicine?
Yes, it is on the WHO Model List of Essential Medicines.
What is the dose of Ledipasvir/sofosbuvir?
Not provided here. Ask a doctor or pharmacist.
Ledipasvir/sofosbuvir क्या है?
Ledipasvir/sofosbuvir is an essential medicine on the WHO Model List, listed under: Non-pangenotypic direct-acting antiviral combinations. A product label is not available in our sources.
स्रोत: WHO Model List of Essential Medicines, 23rd list (2023) · Reference · Reference
WHO Model List of Essential Medicines, 23rd list (2023), World Health Organization